KORU Medical Systems
Mahwah, United States · Biotechnology, Health Care, Manufacturing
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for
Key facts
- Headquarters
- Mahwah, United States
- Employees
- 103
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Public (KRMD)
- Website
- www.korumedical.com
- Company page
Recent activity at KORU Medical Systems
- : KORU Medical Systems Appoints Eric Schiller as Chief Technology Officer
- : SEC 8-K (1.01):
- : SEC 8-K (1.01): On March 30, 2026, KORU Medical Systems, Inc. entered into an amendment to its loan and security agreement with HSBC Ventures USA Inc., extending the maturity of its $5,000,000 revolving credit facility and $5,000,000 term loan facility. The amendment extends the maturity of the Revolver to March 30, 2028, and the Term Loan to December 1, 2029. Adjustments include lowering the interest rate floor from 6.50% to 5.50% and removing the adjusted quick ratio covenant, replacing it with a liquidity covenant. The significant financial implications involve the adjustment of repayment terms through 2029, enhancing the company's financial flexibility over the next several years.
- : SEC 8-K (5.02):
- : SEC 8-K (2.02): On January 12, 2026, KORU Medical Systems, Inc. released preliminary financial results for the fiscal quarter and year ended December 31, 2025. This disclosure provides initial estimates of the company's financial performance, which are still subject to change pending final review and closing procedures. The press release highlights the company's financial results, which could be important for investors and decision-makers. Although specific financial figures were not detailed in the filing, the announcement signals important insights into the company's operational performance over the past fiscal year.
- : SEC 8-K (1.01):
- : KORU Medical Systems Signs Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System (date Fundz recorded it)
- : KORU Medical Systems Launches KORU FreedomEdge® Infusion System Promoting Enhanced Oncology Infusion Experiences.
- : KORU Medical Systems Promotes Christopher Pazdan to Chief Operating Officer
- : KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Leadership
- Eric Schiller, Chief Technology Officer
- Christopher Pazdan, Chief Operating Officer
- Ken Miller, Chief Commercial Officer
- Andrew LaFrence, Chief Financial Officer
Verified email and direct lines for KORU Medical Systems’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
KORU Medical Systems in the news
- KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA - Yahoo Finance (Nov 10, 2026)
- KORU Medical Systems to Participate in Upcoming Investor Conferences - Business Wire (Nov 04, 2026)
- KORU Medical Systems Announces CEO Transition - BioSpace (Mar 13, 2026)
- KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility - BioSpace (Mar 13, 2026)
- KORU Medical Systems Announces 27% Q3 Revenue Growth and Raises 2025 Revenue Guidance - Business Wire (Nov 12, 2025)
- KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems - Business Wire (Nov 04, 2025)
Companies similar to KORU Medical Systems
- Blue Earth Diagnostics · Biotechnology, Health Care, Manufacturing, Medical Device
- Visage Imaging · Biotechnology, Health Care, Manufacturing, Medical Device
- ZAP Surgical Systems · Biotechnology, Health Care, Manufacturing, Medical Device
- Shimadzu Medical Systems USA · Biotechnology, Health Care, Manufacturing, Medical Device
- P&F Products & Features GmbH · Biotechnology, Health Care, Manufacturing, Medical Device
About KORU Medical Systems: questions and answers
What does KORU Medical Systems do?
KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use subcutaneous drug delivery systems that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for
Where is KORU Medical Systems headquartered?
KORU Medical Systems is headquartered in Mahwah, United States.
How many employees does KORU Medical Systems have?
KORU Medical Systems has about 103 employees.
What is the latest news on KORU Medical Systems?
On Dec 16, 2025, KORU Medical Systems Appoints Eric Schiller as Chief Technology Officer
Is KORU Medical Systems a public company?
Yes. KORU Medical Systems is publicly traded under the ticker KRMD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy